These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6949608)

  • 1. Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.
    Pinkerton CR; Welshman SG; Bridges JM
    Br J Cancer; 1982 Feb; 45(2):300-3. PubMed ID: 6949608
    [No Abstract]   [Full Text] [Related]  

  • 2. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.
    Kearney PJ; Light PA; Preece A; Mott MG
    Cancer Chemother Pharmacol; 1979; 3(2):117-20. PubMed ID: 292536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.
    Pearson AD; Mills S; Amineddine HA; Long DR; Craft AW; Chessells JM
    Cancer Chemother Pharmacol; 1987; 20(3):243-7. PubMed ID: 3315283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Altered plasma pharmacokinetics of methotrexate administered intrathecally.
    Jacobs SA; Bleyer WA; Chabner BA; Johns DG
    Lancet; 1975 Feb; 1(7904):465-6. PubMed ID: 48664
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
    Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
    Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?
    Pinkerton CR; Welshman SG; Glasgow JF; Bridges JM
    Lancet; 1980 Nov; 2(8201):944-6. PubMed ID: 6107590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate and folate content of erythrocytes in patients receiving oral vs intramuscular therapy with methotrexate.
    Kamen BA; Holcenberg JS; Turo K; Whitehead VM
    J Pediatr; 1984 Jan; 104(1):131-3. PubMed ID: 6581287
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose methotrexate in acute lymphocytic leukemia.
    Freeman AI; Wang JJ; Sinks LF
    Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic management of remissions in acute lymphoblastic leukemia in children].
    Armata J
    Pol Tyg Lek; 1970 Nov; 25(44):1670-2. PubMed ID: 4921264
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone-marrow toxicity of methotrexate: a reassessment.
    Douglas ID; Price LA
    Br J Haematol; 1973 May; 24(5):625-31. PubMed ID: 4514552
    [No Abstract]   [Full Text] [Related]  

  • 11. New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. Acute leukemia group B.
    JAMA; 1965 Oct; 194(1):75-81. PubMed ID: 5896942
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
    Pearson AD; Amineddine HA; Yule M; Mills S; Long DR; Craft AW; Chessells JM
    Br J Cancer; 1991 Jul; 64(1):169-73. PubMed ID: 1854617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate bioavailability after oral and intramuscular administration in children.
    Teresi ME; Crom WR; Choi KE; Mirro J; Evans WE
    J Pediatr; 1987 May; 110(5):788-92. PubMed ID: 3471936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of childhood acute lymphoblastic leukemia: efficacy of intermittent pulses of 6-mercaptopurine and methotrexate for maintenance chemotherapy, CCLSG-S811 (phase III study). Children's Cancer and Leukemia Study Group].
    Koizumi S; Fujimoto T; Takeda T; Yatabe M; Katou K; Kaneko A; Sekine I; Takeshita T; Utsumi J; Kubota H
    Rinsho Ketsueki; 1987 Aug; 28(8):1375-84. PubMed ID: 3323563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of nitrogen mustard to maintain remission of acute lymphoblastic leukemia in children].
    Silva Sosa M; Sedas T; Ajuria E
    Bol Med Hosp Infant Mex; 1974; 31(4):785-98. PubMed ID: 4529618
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate absorption in children with acute lymphoblastic leukemia.
    Craft AW; Rankin A; Aherne W
    Cancer Treat Rep; 1981; 65 Suppl 1():77-81. PubMed ID: 6948609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methotrexate levels in the blood and cerebrospinal fluid in children with acute lymphoid leukemia treated with medium doses of methotrexate].
    Borsi J; Koós R; Révész T; Schuler D
    Orv Hetil; 1984 Oct; 125(44):2667-8, 2671-3. PubMed ID: 6387586
    [No Abstract]   [Full Text] [Related]  

  • 18. Remission induction of meningeal leukemia with high-dose intravenous methotrexate.
    Balis FM; Savitch JL; Bleyer WA; Reaman GH; Poplack DG
    J Clin Oncol; 1985 Apr; 3(4):485-9. PubMed ID: 3856631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of oral methotrexate absorption in children with leukemia.
    Mahony MJ; Murphy MS; Wadsworth J; Mott MG
    Cancer Chemother Pharmacol; 1984; 12(2):131-3. PubMed ID: 6583027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse.
    Morse M; Savitch J; Balis F; Miser J; Feusner J; Reaman G; Poplack D; Bleyer A
    J Clin Oncol; 1985 Jan; 3(1):19-24. PubMed ID: 3855310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.